Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans

BACKGROUND: Subcutaneous venom immunotherapy (VIT) represents an effective treatment against bee venom allergy. However, it involves long treatment times, high costs, and the risk of adverse events (AEs). Shorter, safer, and cheaper treatment options are therefore pursued. OBJECTIVE: To determine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chabot, Alexandra, Senti, Gabriela, Erdmann, Iris, Prinz, Bettina M., Wüthrich, Brunello, Šošić, Lara, Kündig, Thomas M., Johansen, Pål
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974761/
https://www.ncbi.nlm.nih.gov/pubmed/35386649
http://dx.doi.org/10.3389/falgy.2022.832010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974761/
https://www.ncbi.nlm.nih.gov/pubmed/35386649
http://dx.doi.org/10.3389/falgy.2022.832010

Ejemplares similares